Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Aureka Biotechnologies has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Aureka Biotechnologies's investors include Qiming Venture Partners, Matrix Partners China, 5Y Capital, K2VC, HongShan.
Aureka Biotechnologies is headquartered in Laguna Hills, United States.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Aureka Biotechnologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aureka Biotechnologies — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/aureka-biotechnologies. Accessed September 7, 2026.
VCBacked. (2026). Aureka Biotechnologies — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/aureka-biotechnologies
{{cite web |title=Aureka Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/aureka-biotechnologies |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated